Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death

被引:163
作者
Burnstock, G. [1 ]
Verkhratsky, A. [2 ,3 ]
机构
[1] Royal Free & Univ Coll Med Sch, Auton Neurosci Ctr, London NW3 2PF, England
[2] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England
[3] ASCR, Inst Expt Med, Prague, Czech Republic
关键词
REFRACTORY PROSTATE-CANCER; ADENOSINE A(1) RECEPTOR; VASCULAR SMOOTH-MUSCLE; KNOCK-OUT MICE; EXTRACELLULAR ATP; P2X RECEPTORS; INTERNATIONAL UNION; NUCLEOTIDE RECEPTOR; IN-VIVO; DICTYOSTELIUM-DISCOIDEUM;
D O I
10.1038/cddis.2009.11
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The purinergic signalling system, which uses purines and pyrimidines as chemical transmitters, and purinoceptors as effectors, is deeply rooted in evolution and development and is a pivotal factor in cell communication. The ATP and its derivatives function as a 'danger signal' in the most primitive forms of life. Purinoceptors are extraordinarily widely distributed in all cell types and tissues and they are involved in the regulation of an even more extraordinary number of biological processes. In addition to fast purinergic signalling in neurotransmission, neuromodulation and secretion, there is long-term (trophic) purinergic signalling involving cell proliferation, differentiation, motility and death in the development and regeneration of most systems of the body. In this article, we focus on the latter in the immune/defence system, in stratified epithelia in visceral organs and skin, embryological development, bone formation and resorption, as well as in cancer. Cell Death and Disease (2010) 1, e9; doi:10.1038/cddis.2009.11; published online 14 January 2010
引用
收藏
页码:e9 / e9
页数:10
相关论文
共 144 条
[1]  
Abbracchio M.P., 2006, NOVART FDN SYMP, V276, P103, DOI DOI 10.1002/9780470032244.CH8
[2]  
Abbracchio M.P., 2006, NOVART FDN SYMP, V276, P275, DOI DOI 10.1002/9780470032244.CH8
[3]   Roles of P2 receptors in glial cells: focus on astrocytes [J].
Maria P. Abbracchio ;
Stefania Ceruti .
Purinergic Signalling, 2006, 2 (4) :595-604
[4]  
Abbracchio Maria P, 2006, Novartis Found Symp, V276, P91
[5]   International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy [J].
Abbracchio, Maria P. ;
Burnstock, Geoffrey ;
Boeynaems, Jean-Marie ;
Barnard, Eric A. ;
Boyer, Jose L. ;
Kennedy, Charles ;
Knight, Gillian E. ;
Fumagalli, Marta ;
Gachet, Christian ;
Jacobson, Kenneth A. ;
Weisman, Gary A. .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :281-341
[6]   Purinergic signalling in the nervous system: an overview [J].
Abbracchio, Maria P. ;
Burnstock, Geoffrey ;
Verkhratsky, Alexei ;
Zimmermann, Herbert .
TRENDS IN NEUROSCIENCES, 2009, 32 (01) :19-29
[7]   MODULATION OF ASTROGLIAL CELL-PROLIFERATION BY ANALOGS OF ADENOSINE AND ATP IN PRIMARY CULTURES OF RAT STRIATUM [J].
ABBRACCHIO, MP ;
SAFFREY, MJ ;
HOPKER, V ;
BURNSTOCK, G .
NEUROSCIENCE, 1994, 59 (01) :67-76
[8]   Purinergic signalling: Pathophysiological roles [J].
Abbracchio, MP ;
Burnstock, G .
JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 78 (02) :113-145
[9]   Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes:: studies of cells from A2A-receptor-gene-deficient mice [J].
Armstrong, JM ;
Chen, JF ;
Schwarzschild, MA ;
Apasov, S ;
Smith, PT ;
Caldwell, C ;
Chen, P ;
Figler, H ;
Sullivan, G ;
Fink, S ;
Linden, J ;
Sitkovsky, M .
BIOCHEMICAL JOURNAL, 2001, 354 :123-130
[10]  
Avila MY, 2002, INVEST OPHTH VIS SCI, V43, P3021